{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:26:21Z","timestamp":1791296781443,"version":"4.1.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13071-016-1721-0","type":"journal-article","created":{"date-parts":[[2016,8,23]],"date-time":"2016-08-23T16:16:00Z","timestamp":1471968960000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":128,"title":["The immunology of post-kala-azar dermal leishmaniasis (PKDL)"],"prefix":"10.1186","volume":"9","author":[{"given":"Eduard E.","family":"Zijlstra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,23]]},"reference":[{"issue":"2","key":"1721_CR1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1473-3099(03)00517-6","volume":"3","author":"EE Zijlstra","year":"2003","unstructured":"Zijlstra EE, Musa AM, Khalil EA, el-Hassan IM, el-Hassan AM. Post-kala-azar dermal leishmaniasis. Lancet Infect Dis. 2003;3(2):87\u201398. Epub 2003\/02\/01.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"1721_CR2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0035-9203(93)90024-K","volume":"87","author":"EE Zijlstra","year":"1993","unstructured":"Zijlstra EE, el-Hassan AM. Leishmanin and tuberculin sensitivity in leishmaniasis in the Sudan, with special reference to kala-azar. Trans R Soc Trop Med Hyg. 1993;87(4):425\u20137. Epub 1993\/07\/01.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"8","key":"1721_CR3","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1179\/000349802125002211","volume":"96","author":"AM Musa","year":"2002","unstructured":"Musa AM, Khalil EA, Raheem MA, Zijlstra EE, Ibrahim ME, Elhassan IM, et al. The natural history of Sudanese post-kala-azar dermal leishmaniasis: clinical, immunological and prognostic features. Ann Trop Med Parasitol. 2002;96(8):765\u201372. Epub 2003\/03\/11.","journal-title":"Ann Trop Med Parasitol"},{"issue":"5","key":"1721_CR4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1365-3083.1997.d01-154.x","volume":"46","author":"K Kemp","year":"1997","unstructured":"Kemp K, Hviid L, Kharazmi A, Kemp M. Interferon-gamma production by human T cells and natural killer cells in vitro in response to antigens from the two intracellular pathogens Mycobacterium tuberculosis and Leishmania major. Scand J Immunol. 1997;46(5):495\u20139. Epub 1997\/12\/11.","journal-title":"Scand J Immunol"},{"issue":"4\u20135","key":"1721_CR5","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0171-2985(89)80045-2","volume":"179","author":"M Lohoff","year":"1989","unstructured":"Lohoff M, Sommer F, Solbach W, Rollinghoff M. Coexistence of antigen-specific TH1 and TH2 cells in genetically susceptible BALB\/c mice infected with Leishmania major. Immunobiology. 1989;179(4\u20135):412\u201321. Epub 1989\/10\/01.","journal-title":"Immunobiology"},{"issue":"2","key":"1721_CR6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1699-0463.1994.tb04850.x","volume":"102","author":"M Kemp","year":"1994","unstructured":"Kemp M, Kurtzhals JA, Kharazmi A, Theander TG. Dichotomy in the human CD4+ T-cell response to Leishmania parasites. APMIS. 1994;102(2):81\u20138. Epub 1994\/02\/01.","journal-title":"APMIS"},{"issue":"4","key":"1721_CR7","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/jid.2009.393","volume":"130","author":"S Ganguly","year":"2010","unstructured":"Ganguly S, Mukhopadhyay D, Das NK, Chaduvula M, Sadhu S, Chatterjee U, et al. Enhanced lesional Foxp3 expression and peripheral anergic lymphocytes indicate a role for regulatory T cells in Indian post-kala-azar dermal leishmaniasis. J Invest Dermatol. 2010;130(4):1013\u201322. Epub 2009\/12\/25.","journal-title":"J Invest Dermatol"},{"issue":"7","key":"1721_CR8","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.4049\/jimmunol.0804024","volume":"183","author":"CF Anderson","year":"2009","unstructured":"Anderson CF, Stumhofer JS, Hunter CA, Sacks D. IL-27 regulates IL-10 and IL-17 from CD4+ cells in nonhealing Leishmania major infection. J Immunol. 2009;183(7):4619\u201327. Epub 2009\/09\/15.","journal-title":"J Immunol"},{"issue":"2","key":"1721_CR9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4103\/0974-777X.62876","volume":"2","author":"S Nylen","year":"2010","unstructured":"Nylen S, Gautam S. Immunological perspectives of leishmaniasis. J Global Infect Dis. 2010;2(2):135\u201346. Epub 2010\/07\/08.","journal-title":"J Global Infect Dis"},{"issue":"1\u20132","key":"1721_CR10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0165-2478(98)00132-1","volume":"65","author":"A Kharazmi","year":"1999","unstructured":"Kharazmi A, Kemp K, Ismail A, Gasim S, Gaafar A, Kurtzhals JA, et al. T-cell response in human leishmaniasis. Immunol Lett. 1999;65(1\u20132):105\u20138. Epub 1999\/03\/05.","journal-title":"Immunol Lett"},{"issue":"6","key":"1721_CR11","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1128\/CVI.00143-12","volume":"19","author":"OP Singh","year":"2012","unstructured":"Singh OP, Gidwani K, Kumar R, Nylen S, Jones SL, Boelaert M, et al. Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood. Clin Vaccine Immunol. 2012;19(6):961\u20136. Epub 2012\/04\/28.","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"1721_CR12","doi-asserted-by":"crossref","first-page":"e0004375","DOI":"10.1371\/journal.pntd.0004375","volume":"10","author":"PL Santos Dos","year":"2016","unstructured":"Dos Santos PL, de Oliveira FA, Santos ML, Cunha LC, Lino MT, de Oliveira MF, et al. The severity of visceral leishmaniasis correlates with elevated levels of serum IL-6, IL-27 and sCD14. PLoS Negl Trop Dis. 2016;10(1):e0004375. Epub 2016\/01\/28.","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"1721_CR13","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/infdis\/jir461","volume":"204","author":"S Gautam","year":"2011","unstructured":"Gautam S, Kumar R, Maurya R, Nylen S, Ansari N, Rai M, et al. IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis. J Infect Dis. 2011;204(7):1134\u20137. Epub 2011\/09\/02.","journal-title":"J Infect Dis"},{"issue":"4","key":"1721_CR14","doi-asserted-by":"crossref","first-page":"e10107","DOI":"10.1371\/journal.pone.0010107","volume":"5","author":"S Verma","year":"2010","unstructured":"Verma S, Kumar R, Katara GK, Singh LC, Negi NS, Ramesh V, et al. Quantification of parasite load in clinical samples of leishmaniasis patients: IL-10 level correlates with parasite load in visceral leishmaniasis. PLoS One. 2010;5(4):e10107. Epub 2010\/04\/21.","journal-title":"PLoS One"},{"issue":"2","key":"1721_CR15","doi-asserted-by":"crossref","first-page":"e0004422","DOI":"10.1371\/journal.pntd.0004422","volume":"10","author":"P Bhattacharya","year":"2016","unstructured":"Bhattacharya P, Ghosh S, Ejazi SA, Rahaman M, Pandey K, Ravi Das VN, et al. Induction of IL-10 and TGFbeta from CD4+CD25+FoxP3+ T cells correlates with parasite load in Indian Kala-azar patients infected with leishmania donovani. PLoS Negl Trop Dis. 2016;10(2):e0004422. Epub 2016\/02\/02.","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"1721_CR16","doi-asserted-by":"crossref","first-page":"e2914","DOI":"10.1371\/journal.pntd.0002914","volume":"8","author":"RJ Faleiro","year":"2014","unstructured":"Faleiro RJ, Kumar R, Hafner LM, Engwerda CR. Immune regulation during chronic visceral leishmaniasis. PLoS Negl Trop Dis. 2014;8(7):e2914. Epub 2014\/07\/11.","journal-title":"PLoS Negl Trop Dis"},{"key":"1721_CR17","doi-asserted-by":"crossref","unstructured":"Khalil EA, Ayed NB, Musa AM, Ibrahim ME, Mukhtar MM, Zijlstra EE, Elhassan IM, Smith PG, Kieny PM, Ghalib HW, Zicker F, Modabber F, Elhassan AM. Dichotomy of protective cellular immune responses to human leishmaniasis. Clin Exp Immunol. 2005;140(2):349-53","DOI":"10.1111\/j.1365-2249.2005.02768.x"},{"issue":"7","key":"1721_CR18","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.4049\/jimmunol.1003588","volume":"186","author":"NA Ansari","year":"2011","unstructured":"Ansari NA, Kumar R, Gautam S, Nylen S, Singh OP, Sundar S, et al. IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis. J Immunol. 2011;186(7):3977\u201385. Epub 2011\/03\/02.","journal-title":"J Immunol"},{"issue":"8","key":"1721_CR19","first-page":"2379","volume":"119","author":"MG Pitta","year":"2009","unstructured":"Pitta MG, Romano A, Cabantous S, Henri S, Hammad A, Kouriba B, et al. IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani. J Clin Invest. 2009;119(8):2379\u201387. Epub 2009\/07\/22.","journal-title":"J Clin Invest"},{"issue":"1\u20133","key":"1721_CR20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12026-009-8135-4","volume":"47","author":"S Stager","year":"2010","unstructured":"Stager S, Joshi T, Bankoti R. Immune evasive mechanisms contributing to persistent Leishmania donovani infection. Immunol Res. 2010;47(1\u20133):14\u201324. Epub 2010\/01\/21.","journal-title":"Immunol Res"},{"key":"1721_CR21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fimmu.2012.00005","volume":"3","author":"S Stager","year":"2012","unstructured":"Stager S, Rafati S. CD8(+) T cells in leishmania infections: friends or foes? Front Immunol. 2012;3:5. Epub 2012\/05\/09.","journal-title":"Front Immunol"},{"key":"1721_CR22","first-page":"CD009135","volume":"6","author":"M Boelaert","year":"2014","unstructured":"Boelaert M, Verdonck K, Menten J, Sunyoto T, van Griensven J, Chappuis F, et al. Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease. Cochrane Database Syst Rev. 2014;6:CD009135.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"1721_CR23","first-page":"190","volume":"76","author":"S Argov","year":"1989","unstructured":"Argov S, Jaffe CL, Krupp M, Slor H, Shoenfeld Y. Autoantibody production by patients infected with Leishmania. Clin Exp Immunol. 1989;76(2):190\u20137. Epub 1989\/05\/01.","journal-title":"Clin Exp Immunol"},{"key":"1721_CR24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-065X.1989.tb00557.x","volume":"112","author":"P Scott","year":"1989","unstructured":"Scott P, Pearce E, Cheever AW, Coffman RL, Sher A. Role of cytokines and CD4+ T-cell subsets in the regulation of parasite immunity and disease. Immunol Rev. 1989;112:161\u201382. Epub 1989\/12\/01.","journal-title":"Immunol Rev"},{"issue":"10","key":"1721_CR25","doi-asserted-by":"crossref","first-page":"e3198","DOI":"10.1371\/journal.pntd.0003198","volume":"8","author":"R Kumar","year":"2014","unstructured":"Kumar R, Singh N, Gautam S, Singh OP, Gidwani K, Rai M, et al. Leishmania specific CD4 T cells release IFNgamma that limits parasite replication in patients with visceral leishmaniasis. PLoS Negl Trop Dis. 2014;8(10):e3198. Epub 2014\/10\/03.","journal-title":"PLoS Negl Trop Dis"},{"issue":"7","key":"1721_CR26","doi-asserted-by":"crossref","first-page":"e764","DOI":"10.1371\/journal.pntd.0000764","volume":"4","author":"S Mondal","year":"2010","unstructured":"Mondal S, Bhattacharya P, Rahaman M, Ali N, Goswami RP. A curative immune profile one week after treatment of Indian kala-azar patients predicts success with a short-course liposomal amphotericin B therapy. PLoS Negl Trop Dis. 2010;4(7):e764. Epub 2010\/07\/30.","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"1721_CR27","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/infdis\/jir551","volume":"204","author":"D Mukhopadhyay","year":"2011","unstructured":"Mukhopadhyay D, Das NK, Roy S, Kundu S, Barbhuiya JN, Chatterjee M. Miltefosine effectively modulates the cytokine milieu in Indian post kala-azar dermal leishmaniasis. J Infect Dis. 2011;204(9):1427\u201336. Epub 2011\/09\/22.","journal-title":"J Infect Dis"},{"issue":"11","key":"1721_CR28","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.trstmh.2008.05.015","volume":"102","author":"NA Ansari","year":"2008","unstructured":"Ansari NA, Ramesh V, Salotra P. Immune response following miltefosine therapy in a patient with post-kala-azar dermal leishmaniasis. Trans R Soc Trop Med Hyg. 2008;102(11):1160\u20132. Epub 2008\/07\/22.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"1721_CR29","first-page":"41","volume":"74","author":"A Hailu","year":"1997","unstructured":"Hailu A, Berhe N, Ali A, Gemetchu T. Use of Leishmania major derived leishmanin for skin test surveys of visceral leishmaniasis in Ethiopia. East Afr Med J. 1997;74(1):41\u20135. Epub 1997\/01\/01.","journal-title":"East Afr Med J"},{"key":"1721_CR30","doi-asserted-by":"crossref","first-page":"275253","DOI":"10.1155\/2013\/275253","volume":"2013","author":"EA Khalil","year":"2013","unstructured":"Khalil EA, Khidir SA, Musa AM, Musa BY, Elfaki ME, Elkadaru AM, et al. Post-Kala-Azar Dermal Leishmaniasis: a paradigm of paradoxical immune reconstitution syndrome in non-HIV\/AIDS patients. J Trop Med. 2013;2013:275253. Epub 2013\/05\/02.","journal-title":"J Trop Med"},{"issue":"3","key":"1721_CR31","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1046\/j.1365-2249.2000.01163.x","volume":"119","author":"S Gasim","year":"2000","unstructured":"Gasim S, Elhassan AM, Kharazmi A, Khalil EA, Ismail A, Theander TG. The development of post-kala-azar dermal leishmaniasis (PKDL) is associated with acquisition of Leishmania reactivity by peripheral blood mononuclear cells (PBMC). Clin Exp Immunol. 2000;119(3):523\u20139. Epub 2000\/02\/26.","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"1721_CR32","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.mehy.2005.03.035","volume":"66","author":"A Ismail","year":"2006","unstructured":"Ismail A, Khalil EA, Musa AM, El Hassan IM, Ibrahim ME, Theander TG, et al. The pathogenesis of post kala-azar dermal leishmaniasis from the field to the molecule: does ultraviolet light (UVB) radiation play a role? Med Hypotheses. 2006;66(5):993\u20139. Epub 2006\/01\/03.","journal-title":"Med Hypotheses"},{"issue":"7","key":"1721_CR33","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1086\/506624","volume":"194","author":"NA Ansari","year":"2006","unstructured":"Ansari NA, Ramesh V, Salotra P. Interferon (IFN)-gamma, tumor necrosis factor-alpha, interleukin-6, and IFN-gamma receptor 1 are the major immunological determinants associated with post-kala azar dermal leishmaniasis. J Infect Dis. 2006;194(7):958\u201365. Epub 2006\/09\/09.","journal-title":"J Infect Dis"},{"issue":"4","key":"1721_CR34","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/(SICI)1096-9896(199912)189:4<615::AID-PATH466>3.0.CO;2-Z","volume":"189","author":"A Ismail","year":"1999","unstructured":"Ismail A, El Hassan AM, Kemp K, Gasim S, Kadaru AE, Moller T, et al. Immunopathology of post kala-azar dermal leishmaniasis (PKDL): T-cell phenotypes and cytokine profile. J Pathol. 1999;189(4):615\u201322. Epub 2000\/01\/12.","journal-title":"J Pathol"},{"issue":"12","key":"1721_CR35","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1086\/588387","volume":"197","author":"S Ganguly","year":"2008","unstructured":"Ganguly S, Das NK, Panja M, Pal S, Modak D, Rahaman M, et al. Increased levels of interleukin-10 and IgG3 are hallmarks of Indian post-kala-azar dermal leishmaniasis. J Infect Dis. 2008;197(12):1762\u201371. Epub 2008\/05\/01.","journal-title":"J Infect Dis"},{"issue":"5","key":"1721_CR36","doi-asserted-by":"crossref","first-page":"e1171","DOI":"10.1371\/journal.pntd.0001171","volume":"5","author":"GK Katara","year":"2011","unstructured":"Katara GK, Ansari NA, Verma S, Ramesh V, Salotra P. Foxp3 and IL-10 expression correlates with parasite burden in lesional tissues of post kala azar dermal leishmaniasis (PKDL) patients. PLoS Negl Trop Dis. 2011;5(5):e1171. Epub 2011\/06\/10.","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"1721_CR37","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/exd.12635","volume":"24","author":"S Mukherjee","year":"2015","unstructured":"Mukherjee S, Mukhopadhyay D, Braun C, Barbhuiya JN, Das NK, Chatterjee U, et al. Decreased presence of Langerhans cells is a critical determinant for Indian Post kala-azar dermal leishmaniasis. Exp Dermatol. 2015;24(3):232\u20134. Epub 2015\/01\/13.","journal-title":"Exp Dermatol"},{"issue":"3","key":"1721_CR38","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2249.2008.03761.x","volume":"154","author":"NA Ansari","year":"2008","unstructured":"Ansari NA, Katara GK, Ramesh V, Salotra P. Evidence for involvement of TNFR1 and TIMPs in pathogenesis of post-kala-azar dermal leishmaniasis. Clin Exp Immunol. 2008;154(3):391\u20138. Epub 2008\/11\/29.","journal-title":"Clin Exp Immunol"},{"issue":"10","key":"1721_CR39","doi-asserted-by":"crossref","first-page":"e0004145","DOI":"10.1371\/journal.pntd.0004145","volume":"9","author":"D Mukhopadhyay","year":"2015","unstructured":"Mukhopadhyay D, Mukherjee S, Roy S, Dalton JE, Kundu S, Sarkar A, et al. M2 polarization of monocytes-macrophages is a hallmark of Indian Post Kala-Azar Dermal Leishmaniasis. PLoS Negl Trop Dis. 2015;9(10):e0004145. Epub 2015\/10\/27.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"1721_CR40","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4269\/ajtmh.12-0711","volume":"89","author":"S Islam","year":"2013","unstructured":"Islam S, Kenah E, Bhuiyan MA, Rahman KM, Goodhew B, Ghalib CM, et al. Clinical and immunological aspects of post-kala-azar dermal leishmaniasis in Bangladesh. Am\u00a0J\u00a0Trop Med Hyg. 2013;89(2):345\u201353. Epub 2013\/07\/03.","journal-title":"Am\u00a0J\u00a0Trop Med Hyg"},{"issue":"6","key":"1721_CR41","doi-asserted-by":"crossref","first-page":"e1703","DOI":"10.1371\/journal.pntd.0001703","volume":"6","author":"GK Katara","year":"2012","unstructured":"Katara GK, Ansari NA, Singh A, Ramesh V, Salotra P. Evidence for involvement of Th17 type responses in post kala azar dermal leishmaniasis (PKDL). PLoS Negl Trop Dis. 2012;6(6):e1703. Epub 2012\/06\/23.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"1721_CR42","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1128\/IAI.42.2.702-707.1983","volume":"42","author":"JP Haldar","year":"1983","unstructured":"Haldar JP, Ghose S, Saha KC, Ghose AC. Cell-mediated immune response in Indian kala-azar and post-kala-azar dermal leishmaniasis. Infect Immun. 1983;42(2):702\u20137. Epub 1983\/11\/01.","journal-title":"Infect Immun"},{"issue":"8","key":"1721_CR43","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.4049\/jimmunol.179.8.5592","volume":"179","author":"S Saha","year":"2007","unstructured":"Saha S, Mondal S, Ravindran R, Bhowmick S, Modak D, Mallick S, et al. IL-10- and TGF-beta-mediated susceptibility in kala-azar and post-kala-azar dermal leishmaniasis: the significance of amphotericin B in the control of Leishmania donovani infection in India. J Immunol. 2007;179(8):5592\u2013603. Epub 2007\/10\/04.","journal-title":"J Immunol"},{"issue":"11","key":"1721_CR44","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.trstmh.2012.07.005","volume":"106","author":"D Mukhopadhyay","year":"2012","unstructured":"Mukhopadhyay D, Das NK, De Sarkar S, Manna A, Ganguly DN, Barbhuiya JN, et al. Evaluation of serological markers to monitor the disease status of Indian post kala-azar dermal leishmaniasis. Trans R Soc Trop Med Hyg. 2012;106(11):668\u201376. Epub 2012\/08\/28.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"1721_CR45","first-page":"321","volume":"53","author":"S Datta","year":"2015","unstructured":"Datta S, Modak D, Sarkar S, Saha B, Mukhopadhyay S. Identification and glycobiological characterization of circulating immune complexes in patients with visceral leishmaniasis and post kala azar dermal leishmaniasis. Indian J Exp Biol. 2015;53(6):321\u20138. Epub 2015\/07\/15.","journal-title":"Indian J Exp Biol"},{"issue":"1","key":"1721_CR46","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1365-2133.2000.03603.x","volume":"143","author":"EE Zijlstra","year":"2000","unstructured":"Zijlstra EE, Khalil EA, Kager PA, El-Hassan AM. Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis. Br J Dermatol. 2000;143(1):136\u201343. Epub 2000\/07\/25.","journal-title":"Br J Dermatol"},{"issue":"10","key":"1721_CR47","doi-asserted-by":"crossref","first-page":"e709","DOI":"10.1371\/journal.pntd.0000709","volume":"4","author":"A Hailu","year":"2010","unstructured":"Hailu A, Musa A, Wasunna M, Balasegaram M, Yifru S, Mengistu G, et al. Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial. PLoS Negl Trop Dis. 2010;4(10):e709. Epub 2010\/11\/05.","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"1721_CR48","first-page":"38","volume":"128","author":"CP Thakur","year":"2008","unstructured":"Thakur CP, Kumar A, Mitra G, Thakur S, Sinha PK, Das P, et al. Impact of amphotericin-B in the treatment of kala-azar on the incidence of PKDL in Bihar, India. Indian J Med Res. 2008;128(1):38\u201344. Epub 2008\/09\/30.","journal-title":"Indian J Med Res"},{"issue":"4","key":"1721_CR49","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1128\/JCM.05966-11","volume":"50","author":"K Pandey","year":"2012","unstructured":"Pandey K, Das VN, Singh D, Das S, Lal CS, Verma N, et al. Post-kala-azar dermal leishmaniasis in a patient treated with injectable paromomycin for visceral leishmaniasis in India. J Clin Microbiol. 2012;50(4):1478\u20139. Epub 2012\/01\/27.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"1721_CR50","doi-asserted-by":"crossref","first-page":"241","DOI":"10.4103\/0019-5154.110848","volume":"58","author":"S Koley","year":"2013","unstructured":"Koley S, Mandal RK, Choudhary S, Bandyopadhyay A. Post-kala-azar dermal leishmaniasis developing in miltefosine-treated visceral leishmaniasis. Indian J Dermatol. 2013;58(3):241. Epub 2013\/06\/01.","journal-title":"Indian J Dermatol"},{"issue":"1","key":"1721_CR51","doi-asserted-by":"crossref","first-page":"e2611","DOI":"10.1371\/journal.pntd.0002611","volume":"8","author":"S Burza","year":"2014","unstructured":"Burza S, Sinha PK, Mahajan R, Sanz MG, Lima MA, Mitra G, et al. Post Kala-Azar dermal leishmaniasis following treatment with 20\u00a0mg\/kg liposomal amphotericin B (Ambisome) for primary visceral leishmaniasis in Bihar, India. PLoS Negl Trop Dis. 2014;8(1):e2611. Epub 2014\/01\/07.","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"1721_CR52","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4103\/0022-3859.118046","volume":"59","author":"VN Das","year":"2013","unstructured":"Das VN, Pandey K, Singh D, Forwood C, Lal CS, Das P. Development of post-kala-azar dermal leishmaniasis in Am Bisome treated visceral leishmaniasis: a possible challenge to elimination program in India. J Postgrad Med. 2013;59(3):226\u20138. Epub 2013\/09\/14.","journal-title":"J Postgrad Med"},{"issue":"6","key":"1721_CR53","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMoa0903627","volume":"362","author":"S Sundar","year":"2010","unstructured":"Sundar S, Chakravarty J, Agarwal D, Rai M, Murray HW. Single-dose liposomal amphotericin B for visceral leishmaniasis in India. N Engl J Med. 2010;362(6):504\u201312. Epub 2010\/02\/12.","journal-title":"N Engl J Med"},{"issue":"3","key":"1721_CR54","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1258\/td.2011.110058","volume":"41","author":"EA Khalil","year":"2011","unstructured":"Khalil EA, Musa AM, Younis BM, Elfaki ME, Zijlstra EE, Elhassan AM. Blindness following visceral leishmaniasis: a neglected post-kala-azar complication. Trop Dr. 2011;41(3):139\u201340. Epub 2011\/06\/17.","journal-title":"Trop Dr"},{"issue":"22","key":"1721_CR55","doi-asserted-by":"crossref","first-page":"9375","DOI":"10.1073\/pnas.0703678104","volume":"104","author":"J Lukes","year":"2007","unstructured":"Lukes J, Mauricio IL, Schonian G, Dujardin JC, Soteriadou K, Dedet JP, et al. Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy. Proc Natl Acad Sci U S A. 2007;104(22):9375\u201380. Epub 2007\/05\/23.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1721_CR56","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4269\/ajtmh.2004.70.613","volume":"70","author":"E Zemanova","year":"2004","unstructured":"Zemanova E, Jirku M, Mauricio IL, Miles MA, Lukes J. Genetic polymorphism within the Leishmania donovani complex: correlation with geographic origin. Am\u00a0J Trop Med Hyg. 2004;70(6):613\u20137. Epub 2004\/06\/24.","journal-title":"Am\u00a0J Trop Med Hyg"},{"issue":"7","key":"1721_CR57","doi-asserted-by":"crossref","first-page":"e2995","DOI":"10.1371\/journal.pntd.0002995","volume":"8","author":"R Guha","year":"2014","unstructured":"Guha R, Das S, Ghosh J, Sundar S, Dujardin JC, Roy S. Antimony resistant Leishmania donovani but not sensitive ones drives greater frequency of potent T-regulatory cells upon interaction with human PBMCs: role of IL-10 and TGF-beta in early immune response. PLoS Negl Trop Dis. 2014;8(7):e2995. Epub 2014\/07\/18.","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"1721_CR58","doi-asserted-by":"crossref","first-page":"e1000907","DOI":"10.1371\/journal.ppat.1000907","volume":"6","author":"AK Haldar","year":"2010","unstructured":"Haldar AK, Yadav V, Singhal E, Bisht KK, Singh A, Bhaumik S, et al. Leishmania donovani isolates with antimony-resistant but not -sensitive phenotype inhibit sodium antimony gluconate-induced dendritic cell activation. PLoS Pathog. 2010;6(5):e1000907. Epub 2010\/05\/27.","journal-title":"PLoS Pathog"},{"issue":"11","key":"1721_CR59","doi-asserted-by":"crossref","first-page":"e3258","DOI":"10.1371\/journal.pntd.0003258","volume":"8","author":"EE Zijlstra","year":"2014","unstructured":"Zijlstra EE. PKDL and other dermal lesions in HIV co-infected patients with Leishmaniasis: review of clinical presentation in relation to immune responses. PLoS Negl Trop Dis. 2014;8(11):e3258. Epub 2014\/11\/21.","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"1721_CR60","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4103\/0378-6323.45111","volume":"74","author":"RG Chaudhary","year":"2008","unstructured":"Chaudhary RG, Bilimoria FE, Katare SK. Diffuse cutaneous leishmaniasis: co-infection with human immunodeficiency virus (HIV). Indian J Dermatol Venereol Leprol. 2008;74(6):641\u20133. Epub 2009\/01\/28.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4","key":"1721_CR61","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s00436-012-2996-5","volume":"111","author":"BV Subba Raju","year":"2012","unstructured":"Subba Raju BV, Gurumurthy S, Kuhls K, Bhandari V, Schnonian G, Salotra P. Genetic typing reveals monomorphism between antimony sensitive and resistant Leishmania donovani isolates from visceral leishmaniasis or post kala-azar dermal leishmaniasis cases in India. Parasitol Res. 2012;111(4):1559\u201368. Epub 2012\/07\/04.","journal-title":"Parasitol Res"},{"issue":"4","key":"1721_CR62","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4103\/0972-9062.213573","volume":"49","author":"AK Gupta","year":"2012","unstructured":"Gupta AK, Narayan S, Verma N, Thakur AK, Das P. Viscerotropic potential of parasites isolated from post-kala-azar dermal leishmaniasis cases: an experimental evidence. J Vector Borne Dis. 2012;49(4):266\u20137. Epub 2013\/02\/23.","journal-title":"J Vector Borne Dis"},{"issue":"3","key":"1721_CR63","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00436-012-3222-1","volume":"112","author":"J Mishra","year":"2013","unstructured":"Mishra J, Madhubala R, Singh S. Visceral and post-Kala-Azar dermal leishmaniasis isolates show significant difference in their in vitro drug susceptibility pattern. Parasitol Res. 2013;112(3):1001\u20139. Epub 2012\/12\/18.","journal-title":"Parasitol Res"},{"issue":"1","key":"1721_CR64","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/sj.gene.6364353","volume":"8","author":"MA Salih","year":"2007","unstructured":"Salih MA, Ibrahim ME, Blackwell JM, Miller EN, Khalil EA, ElHassan AM, et al. IFNG and IFNGR1 gene polymorphisms and susceptibility to post-kala-azar dermal leishmaniasis in Sudan. Genes Immun. 2007;8(1):75\u20138. Epub 2006\/12\/01.","journal-title":"Genes Immun"},{"issue":"6","key":"1721_CR65","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000272457","volume":"13","author":"S Farouk","year":"2010","unstructured":"Farouk S, Salih MA, Musa AM, Blackwell JM, Miller EN, Khalil EA, et al. Interleukin 10 gene polymorphisms and development of post kala-azar dermal leishmaniasis in a selected sudanese population. Public Health Genomics. 2010;13(6):362\u20137. Epub 2010\/01\/07.","journal-title":"Public Health Genomics"},{"issue":"4","key":"1721_CR66","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/1469-0691.12556","volume":"20","author":"J Griensven van","year":"2014","unstructured":"van Griensven J, Carrillo E, Lopez-Velez R, Lynen L, Moreno J. Leishmaniasis in immunosuppressed individuals. Clin Microbiol Infect. 2014;20(4):286\u201399. Epub 2014\/01\/24.","journal-title":"Clin Microbiol Infect"},{"key":"1721_CR67","doi-asserted-by":"crossref","first-page":"351579","DOI":"10.1155\/2013\/351579","volume":"2013","author":"AM Hassan El","year":"2013","unstructured":"El Hassan AM, Khalil EA, Elamin WM, El Hassan LA, Ahmed ME, Musa AM. Misdiagnosis and mistreatment of post-kala-azar dermal leishmaniasis. Case Rep Med. 2013;2013:351579. Epub 2013\/03\/28.","journal-title":"Case Rep Med"},{"issue":"6","key":"1721_CR68","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0035-9203(01)90110-5","volume":"95","author":"K Ritmeijer","year":"2001","unstructured":"Ritmeijer K, Veeken H, Melaku Y, Leal G, Amsalu R, Seaman J, et al. Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome. Trans R Soc Trop Med Hyg. 2001;95(6):668\u201372. Epub 2002\/01\/31.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"8","key":"1721_CR69","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/00002030-200005260-00003","volume":"14","author":"D Wolday","year":"2000","unstructured":"Wolday D, Berhe N, Britton S, Akuffo H. HIV-1 alters T helper cytokines, interleukin-12 and interleukin-18 responses to the protozoan parasite Leishmania donovani. AIDS. 2000;14(8):921\u20139.","journal-title":"AIDS"},{"key":"1721_CR70","doi-asserted-by":"crossref","first-page":"852418","DOI":"10.1155\/2013\/852418","volume":"2013","author":"S Bixler","year":"2013","unstructured":"Bixler S, Mattapallil JJ. Loss and dysregulation of Th17 cells during HIV infection. Clin Dev Immunol. 2013;2013:852418.","journal-title":"Clin Dev Immunol"},{"issue":"2","key":"1721_CR71","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1128\/CMR.00061-07","volume":"21","author":"J Alvar","year":"2008","unstructured":"Alvar J, Aparicio P, Aseffa A, Den Boer M, Canavate C, Dedet JP, et al. The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev. 2008;21(2):334\u201359. table of contents. Epub 2008\/04\/11.","journal-title":"Clin Microbiol Rev"},{"issue":"9241","key":"1721_CR72","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(00)03128-7","volume":"356","author":"EA Khalil","year":"2000","unstructured":"Khalil EA, El Hassan AM, Zijlstra EE, Mukhtar MM, Ghalib HW, Musa B, et al. Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan. Lancet. 2000;356(9241):1565\u20139. Epub 2000\/11\/15.","journal-title":"Lancet"},{"issue":"5","key":"1721_CR73","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0264-410X(98)00220-5","volume":"17","author":"AZ Momeni","year":"1999","unstructured":"Momeni AZ, Jalayer T, Emamjomeh M, Khamesipour A, Zicker F, Ghassemi RL, et al. A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran. Vaccine. 1999;17(5):466\u201372. Epub 1999\/03\/12.","journal-title":"Vaccine"},{"issue":"4","key":"1721_CR74","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1179\/146532806X152890","volume":"26","author":"EA Khalil","year":"2006","unstructured":"Khalil EA, Musa AM, Modabber F, El-Hassan AM. Safety and immunogenicity of a candidate vaccine for visceral leishmaniasis (Alum-precipitated autoclaved Leishmania major + BCG) in children: an extended phase II study. Ann Trop Paediatr. 2006;26(4):357\u201361. Epub 2006\/11\/30.","journal-title":"Ann Trop Paediatr"},{"issue":"1","key":"1721_CR75","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.trstmh.2007.08.006","volume":"102","author":"AM Musa","year":"2008","unstructured":"Musa AM, Khalil EA, Mahgoub FA, Elgawi SH, Modabber F, Elkadaru AE, et al. Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment. Trans R Soc Trop Med Hyg. 2008;102(1):58\u201363. Epub 2007\/10\/30.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"1721_CR76","doi-asserted-by":"crossref","first-page":"e0004415","DOI":"10.1371\/journal.pntd.0004415","volume":"10","author":"RJ Faleiro","year":"2016","unstructured":"Faleiro RJ, Kumar R, Bunn PT, Singh N, Chauhan SB, Sheel M, et al. Combined immune therapy for the treatment of visceral leishmaniasis. PLoS Negl Trop Dis. 2016;10(2):e0004415. Epub 2016\/02\/13.","journal-title":"PLoS Negl Trop Dis"},{"key":"1721_CR77","unstructured":"World Health Organization. The Post Kala-azar Dermal Leishmaniasis (PKDL) Atlas: A Manual for Health Workers. ISBN 978 92 4 150410 2 (NLM classification: WC 715) WHO\/HTM\/NTD\/IDM\/2012.4. ( http:\/\/apps.who.int\/iris\/bitstream\/10665\/101164\/1\/9789241504102_eng.pdf )."}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-016-1721-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T01:01:37Z","timestamp":1718758897000},"score":1,"resource":{"primary":{"URL":"http:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-016-1721-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,23]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1721"],"URL":"https:\/\/doi.org\/10.1186\/s13071-016-1721-0","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,23]]},"article-number":"464"}}